Marc Adler

1.8k total citations
35 papers, 1.1k citations indexed

About

Marc Adler is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Marc Adler has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Hematology. Recurrent topics in Marc Adler's work include Protein Structure and Dynamics (8 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Peptidase Inhibition and Analysis (4 papers). Marc Adler is often cited by papers focused on Protein Structure and Dynamics (8 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Peptidase Inhibition and Analysis (4 papers). Marc Adler collaborates with scholars based in United States, Sweden and Mexico. Marc Adler's co-authors include Gerhard Wagner, Robert A. Lazarus, Mark S. Dennis, Marc Whitlow, David R. Light, Monica J. Kochanny, Galina Rumennik, Harold A. Scheraga, Gary B. Phillips and Judi Bryant and has published in prestigious journals such as Science, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Marc Adler

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Adler United States 19 649 168 168 166 136 35 1.1k
Joseph W. Leone United States 17 888 1.4× 134 0.8× 90 0.5× 104 0.6× 267 2.0× 38 1.5k
Ana Negri Spain 18 649 1.0× 146 0.9× 155 0.9× 130 0.8× 119 0.9× 31 1.1k
Kenneth M. Comess United States 16 756 1.2× 189 1.1× 327 1.9× 70 0.4× 279 2.1× 17 1.2k
John Porter United Kingdom 19 548 0.8× 241 1.4× 80 0.5× 43 0.3× 213 1.6× 38 1.1k
Melissa S. Egbertson United States 20 771 1.2× 535 3.2× 215 1.3× 224 1.3× 97 0.7× 35 1.8k
Rashid Syed United States 14 724 1.1× 143 0.9× 47 0.3× 287 1.7× 198 1.5× 15 1.5k
Benjamin R. Bowen United States 18 875 1.3× 239 1.4× 149 0.9× 32 0.2× 112 0.8× 25 1.2k
James M. Samanen United States 21 597 0.9× 347 2.1× 251 1.5× 165 1.0× 110 0.8× 34 1.1k
Judd Berman United States 20 852 1.3× 246 1.5× 62 0.4× 67 0.4× 353 2.6× 43 1.5k
Jakob Fuhrmann United States 20 947 1.5× 123 0.7× 61 0.4× 58 0.3× 219 1.6× 27 1.4k

Countries citing papers authored by Marc Adler

Since Specialization
Citations

This map shows the geographic impact of Marc Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Adler more than expected).

Fields of papers citing papers by Marc Adler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Adler. The network helps show where Marc Adler may publish in the future.

Co-authorship network of co-authors of Marc Adler

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Adler. A scholar is included among the top collaborators of Marc Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Adler. Marc Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sundaram, Aparna, Chun Chen, Nilgun Isik Reed, et al.. (2020). Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness. Bioorganic & Medicinal Chemistry Letters. 30(22). 127578–127578. 5 indexed citations
2.
3.
Islam, Imadul, Shendong Yuan, Christopher W. West, et al.. (2018). Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorganic & Medicinal Chemistry Letters. 28(20). 3372–3375. 4 indexed citations
4.
Garofalo, Albert W., Marc Adler, Danielle L. Aubele, et al.. (2013). Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 1974–1977. 23 indexed citations
5.
Franzini, Maurizio, Marc Adler, Danielle L. Aubele, et al.. (2013). Triazolopyridazine LRRK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 1967–1973. 24 indexed citations
6.
West, Christopher W., Marc Adler, Elena Ho, et al.. (2009). Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA). Bioorganic & Medicinal Chemistry Letters. 19(19). 5712–5715. 11 indexed citations
7.
Kirkland, Thomas A., Marc Adler, John G. Bauman, et al.. (2008). Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase. Bioorganic & Medicinal Chemistry. 16(9). 4963–4983. 29 indexed citations
8.
Adler, Marc, Brad O. Buckman, Judi Bryant, et al.. (2008). Structures of potent selective peptide mimetics bound to carboxypeptidase B. Acta Crystallographica Section D Biological Crystallography. 64(2). 149–157. 17 indexed citations
9.
Whitlow, Marc, Marc Adler, David D. Davey, et al.. (2007). The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase. Bioorganic & Medicinal Chemistry Letters. 17(9). 2505–2508. 6 indexed citations
10.
Islam, Imadul, Greg Brown, Judi Bryant, et al.. (2007). Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517. Bioorganic & Medicinal Chemistry Letters. 17(14). 3819–3825. 35 indexed citations
11.
Islam, Imadul, Judi Bryant, Karen May, et al.. (2006). 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorganic & Medicinal Chemistry Letters. 17(5). 1349–1354. 25 indexed citations
12.
Feldman, Richard I., James M. Wu, Mark A. Polokoff, et al.. (2005). Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1. Journal of Biological Chemistry. 280(20). 19867–19874. 171 indexed citations
13.
Adler, Marc & Stewart A. Thompson. (1999). The Solution Structure of Heregulin-α and a N-Terminal Mutant with Suppressed Activity. Biochemical and Biophysical Research Communications. 256(1). 156–161. 5 indexed citations
14.
Harris, Angela J., Marc Adler, Richard Z. Lin, et al.. (1998). Homologue Scanning Mutagenesis of Heregulin Reveals Receptor Specific Binding Epitopes. Biochemical and Biophysical Research Communications. 251(1). 220–224. 6 indexed citations
15.
Adler, Marc. (1996). Deviation versus violation plots: A new technique for assessing the self-consistency of NMR data. Journal of Biomolecular NMR. 8(4). 404–16. 1 indexed citations
16.
Adler, Marc, et al.. (1995). The Structure of a 19-Residue Fragment from the C-loop of the Fourth Epidermal Growth Factor-like Domain of Thrombomodulin. Journal of Biological Chemistry. 270(40). 23366–23372. 20 indexed citations
17.
Adler, Marc, Paul Carter, Robert A. Lazarus, & Gerhard Wagner. (1993). Cysteine pairing in the glycoprotien IIbIIIa antagonist kistrin using NMR, chemical analysis, and structure calculations. Biochemistry. 32(1). 282–289. 32 indexed citations
18.
Wagner, Gerhard, V. Thanabal, Brian J. Stockman, et al.. (1992). NMR studies of structure and dynamics of isotope enriched proteins. Biopolymers. 32(4). 381–390. 9 indexed citations
19.
Adler, Marc & Harold A. Scheraga. (1990). Nonnative isomers of proline-93 and -114 predominate in heat-unfolded ribonuclease A. Biochemistry. 29(36). 8211–8216. 17 indexed citations
20.
Adler, Marc & Harold A. Scheraga. (1988). Structural studies of a folding intermediate of bovine pancreatic ribonuclease A by continuous recycled flow. Biochemistry. 27(7). 2471–2480. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph W. Leone Breakdown of academic impact, for papers by Ana Negri Breakdown of academic impact, for papers by Kenneth M. Comess Breakdown of academic impact, for papers by John Porter Breakdown of academic impact, for papers by Melissa S. Egbertson Breakdown of academic impact, for papers by Rashid Syed Breakdown of academic impact, for papers by Benjamin R. Bowen Breakdown of academic impact, for papers by James M. Samanen Breakdown of academic impact, for papers by Judd Berman Breakdown of academic impact, for papers by Jakob Fuhrmann
Rankless by CCL
2026